Metastatic multicentric epithelioid angiosarcoma of bone. A case report with pitfalls. Tumor seeding after percutaneous biopsy and hypercalcemia

Author:

Fuentes-Sanchez Jorge1,Pena-Burgos Eva Manuela2,Tapia-Viñe Mar1,Pozo-Kreilinger Jose Juan1,Ortiz-Cruz Eduardo Jose1

Affiliation:

1. Hospital Universitario La Paz

2. Hospital Universitario Príncipe de Asturias

Abstract

Abstract BACKGROUND: Angiosarcomas are a type of malignant tumor of vascular origin. They represent less than 1% of all primary bone tumors. The multicentric or metastatic does not differ in its high aggressiveness and poor prognosis. CASE PRESENTATION: We describe a case of an elderly male with bone angiosarcoma initially located in proximal femur. After biopsy in a non-expert sarcoma center, he presented a tumor involvement in the path of the needle, in additional finding of multicentric/metastatic that involve the sacro-coccygeal level assessed by magnetic resonance imaging. He associated tumoral hypercalcemia secondary to malignancy and was referred to our sarcoma center for therapeutic decision. He was treated by tumoral resection and reconstruction with proximal femur tumor prosthesis due to high risk of pathological fracture. In the early follow-up he presented pulmonary metastasis and new sarcoma implants in soft parts, dying a few months later. CONCLUSIONS: Multicentric and/or metastatic epithelioid angiosarcomas require diagnostic and therapeutic thoroughness to improve the patient's quality of life and survival. Percutaneous biopsies have a risk of tumor seeding in the needle trajectory; therefore, they must be performed in centers with expertise in sarcomas. At present, multicentric or metastatic bone involvement is only of theoretical relevance since the treatment and prognosis are identical. Despite that hypercalcemia in sarcomas is a rare problem, the case has this peculiarity, and we highlight its investigation in some of these cases.

Publisher

Research Square Platform LLC

Reference16 articles.

1. Nielsen GP. Angiosarcoma of bone. JVMG Bovee. WHO Classification of Tumours of Soft Tissue and Bone. 5TH. Lyon: The Who Classification of Tumours Editorial Board; 2020. 434–36.

2. The 2020 WHO Classification of Tumors of Soft Tissue: Selected Changes and New Entities;Choi JH;Adv Anat Pathol,2021

3. Angiosarcoma Outcomes and Prognostic Factors: A 25-Year Single Institution Experience;Buehler D;Am J Clin Oncol,2014

4. Experience of angiosarcoma in the North of England Bone and Soft Tissue Tumour Service;Lewis CJ;J Plast Reconstr Aesthetic Surg,2011

5. Angiosarcoma of bone: a retrospective study of the European Musculoskeletal Oncology Society (EMSOS);Palmerini E;Sci Rep,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3